Time
|
Medication off
|
Medication on
|
---|
UPDRS-III (0 ~ 108)
|
BBS (0 ~ 56)
|
UPDRS-III (0 ~ 108)
|
BBS (0 ~ 56)
|
LEDD (mg)
|
PDQ-39 (0 ~ 124)
|
FOG-Q
|
---|
Preoperative
|
60.0 (23)
|
44 (11)
|
26.2 (23)
|
52 (7)
|
831 (453)
|
49 (38)
|
14 (12)
|
Postoperative
|
1 month
|
35.0 (22)
|
48 (11)
|
15.0 (16)
|
53 (5)
|
–
|
–
|
9 (12)
|
3 month
|
31.5 (12)
|
48 (10)
|
13.0 (13)
|
53 (5)
|
550 (357.5)
|
34 (25)
|
9 (12)
|
6 month
|
31.0 (17)
|
48 (12)
|
12.0 (11)
|
54 (5)
|
475 (220.5)
|
23 (20)
|
9 (10)
|
Total P
|
<0.001
|
0.084
|
<0.001
|
0.058
|
<0.001
|
<0.001
|
0.068
|
χ2
|
109.966
|
35.705
|
74.042
|
29.351
|
62.000
|
104.246
|
7.131
|
P1
|
<0.001
|
–
|
<0.001
|
–
|
–
|
–
|
–
|
P2
|
<0.001
|
–
|
<0.001
|
–
|
< 0.010
|
< 0.010
|
–
|
P3
|
<0.001
|
–
|
<0.001
|
–
|
< 0.010
|
< 0.010
|
–
|
- P1 value is the result of comparison between 1 month and preoperative, P2 value is the result of comparison between 3 months and preoperative, P3 value is the result of comparison between 6 months and preoperative; STN-DBS Subthalamic nucleus - deep brain stimulation, UPDRS-III Unified Parkinson’s Disease Rating ScaleIII, BBS Berg Balance Scale, LEDD Levodopa equivalent dose, PDQ-39 39-Item Parkinson’s Disease Questionnaire, FOG-Q Freeze of gait questionnaire; except LEDD unit is mg, all other index units are points